← Eichor
Condition: Autoantibody Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Autoantibody

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Descartes-08 in Autoantibody Myositis
Phase 2 · 2 location(s) · Cartesian Therapeutics · NCT07391605Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04518475A Placebo-controlled Trial of Folinic Acid in Children With ASD
Phase 2 · 1 location(s) · Prof. Adi Aran · NCT07642661A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease
Phase 2 · 1 location(s) · Arialys Australia Pty Ltd · NCT07093333Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Phase 2 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07103746Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)
NA · 1 location(s) · National Taiwan University Hospital · NCT07726563General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
Phase N/A · 4 location(s) · Sanford Health · NCT04477928Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
Phase N/A · 9 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT06762002Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04993885Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
Phase N/A · 2 location(s) · University Hospital, Grenoble · NCT05193591Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherap
NA · 1 location(s) · University Hospital, Rouen · NCT05689463Early Detection of Type 1 Diabetes
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT06984185Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07477015Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Phase 3 · 84 location(s) · Immunovant Sciences GmbH · NCT07039916Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome
Phase N/A · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT06334692New Biological Tests in Patients With Antiphospholipid Antibodies
Phase N/A · 4 location(s) · Hospices Civils de Lyon · NCT03890601Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06941584A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T
Phase 1/Phase 2 · 13 location(s) · Cabaletta Bio · NCT04422912Impact of the Presence of Anti-interferon Autoantibodies on the Viral Load in Severe Respiratory Infections
Phase N/A · 3 location(s) · Hospices Civils de Lyon · NCT05536219A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients
Phase N/A · 1 location(s) · Rabin Medical Center · NCT06665815Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
Phase N/A · 2 location(s) · University Hospital, Montpellier · NCT05394922Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
NA · 2 location(s) · Sanofi · NCT07038473CAR-T Cells Targeting Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT05459870Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT06435897Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis?
Phase N/A · 2 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT06761209INNODIA Family & Friends Early-Stage T1D Detection Protocol
Phase N/A · 15 location(s) · INNODIA iVZW · NCT07118098Immune Mechanisms of Antipsychotic Treatment Response
Phase N/A · 1 location(s) · King's College London · NCT06687694Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS
Phase N/A · 1 location(s) · Charite University, Berlin, Germany · NCT07529197Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
Phase N/A · 1 location(s) · Gilles Boire · NCT00512239UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07441525
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.